(41) reported that EphA2 knockout mice fed a high-fat diet developed significantly less hepatic steatosis and inflammation than wild-type controls, suggesting that excessive or dysregulated EPHA2 signaling may exacerbate MASLD progression. The gene discussed is EPHA2; the disease is metabolic dysfunction-associated steatotic liver disease.